Company Info
Phone(256) 512-9200
Year Established
1990
Ticker
NKTR
Exchange
NASDAQ
Contacts
Howard RobinPresident & CEO
Mary Tagliaferri
CMO
Sandra Gardiner
CFO
Mark A. Wilson
CLO
Jonathan Zalevsky
Chief Research & Development Officer
Jennifer Ruddock
CBO
Company Description
Nektar Therapeutics is a biopharmaceutical company focused on the development of investigational medicines in oncology, immunology, and inflammatory diseases.
